The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Corticosteroids Market Between 2026 And 2030?
The corticosteroids market has experienced significant growth in recent years. It is anticipated to increase from $5.93 billion in 2025 to $6.33 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. This historic expansion can be attributed to the rising prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread hospital adoption of steroid therapies, increased awareness regarding inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.
The corticosteroids market is projected to experience substantial expansion in the coming years, with its valuation set to reach $8.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This anticipated growth during the forecast period stems from several factors, including the increasing prevalence of autoimmune and respiratory diseases, advancements in developing safer steroid formulations, the worldwide aging demographic, improved healthcare accessibility in developing nations, and enhanced funding for corticosteroid research. Key developments expected within this period encompass the emergence of targeted corticosteroid formulations, therapies involving lower doses and shorter durations, an increase in the adoption of topical and inhaled corticosteroids, combination treatments with bronchodilators, and the expanded application in acute respiratory care settings.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp
What Leading Drivers Are Supporting The Corticosteroids Market Expansion?
The escalating need for cancer treatment is expected to boost the growth of the corticosteroid market in the coming years. Cancer treatment comprises various therapeutic approaches, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted interventions, all aimed at eliminating cancer cells and alleviating associated symptoms. The heightened demand for cancer treatment arises from several contributors, such as a growing incidence of cancer, increased public awareness and screening efforts, enhanced access to healthcare facilities, and the provision of supportive care services. Corticosteroids play a role in improving patient outcomes by easing symptoms and making cancer treatments more tolerable, thereby underpinning the increasing necessity for comprehensive cancer care. For example, in May 2024, the National Health Service (NHS), the UK’s healthcare system, reported that treatment activity reached an all-time high, with over 1,400 patients commencing cancer treatment every working day. Between April 2023 and March 2024, nearly 340,000 individuals received their first cancer treatment. Hence, the rising demand for cancer treatment fuels the expansion of the corticosteroid market.
How Are Segments Identified Within The Corticosteroids Market Segment Framework?
The corticosteroids market covered in this report is segmented –
1) By Product: Glucocorticoids, Mineralocorticoids
2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications
3) By End User: Hospitals, Clinics, Research Institutes, Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids
What Trends Are Affecting The Growth Of The Corticosteroids Market?
Leading firms within the corticosteroids market are creating advanced products, including rescue medications, with the aim of attracting a broader customer base, boosting sales, and enhancing revenue. Rescue medications are defined as treatments or drugs designed to offer rapid and immediate alleviation of acute, severe symptoms of a health condition or sudden worsening of a long-term illness. For example, in January 2023, UK-based pharmaceutical company AstraZeneca PLC disclosed the FDA’s approval for Airsupra (albuterol/budesonide). A key feature of this product is its status as the first-in-class pressurized metered-dose inhaler (pMDI), serving as a fixed-dose combination rescue medication. It combines albuterol, a short-acting beta2-agonist (SABA), with budesonide, an inhaled corticosteroid (ICS) known for its anti-inflammatory effects. This product is prescribed for individuals 18 years and older and can be used as required to treat or prevent bronchoconstriction. Additionally, it contributes to reducing the likelihood of asthma exacerbations. This formulation is accessible in the United States and is being developed by AstraZeneca in partnership with Avillion.
Who Are The Companies Competing Within The Corticosteroids Market?
Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.
Get The Full Corticosteroids Market Report:
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Which Region Leads The Corticosteroids Market In Overall Market Size?
North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Corticosteroids Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company
Drugs For Immunotherapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Metabolic Disorders Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Musculoskeletal Disorder Drugs Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model